日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Corrigendum to Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study Ann Rheum Dis. 2023;82:1404-1414

关于在未接受过生物制剂DMARD治疗的活动性银屑病关节炎患者中应用Bimekizumab治疗的更正：来自III期随机、安慰剂对照、活性参考BE OPTIMAL研究的52周疗效和安全性结果 Ann Rheum Dis. 2023;82:1404-1414

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1016/j.ard.2025.05.013
Ritchlin, Christopher T; Coates, Laura C; McInnes, Iain B; Mease, Philip J; Merola, Joseph F; Tanaka, Yoshiya; Asahina, Akihiko; Gossec, Laure; Gottlieb, Alice B; Warren, Richard B; Ink, Barbara; Bajracharya, Rajan; Shende, Vishvesh; Coarse, Jason; Landewé, Robert B M
关节炎
银屑病
TIM
发表日期：2026
文献求助 收藏

Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis: an updated analysis of six phase IIb/III clinical studies

Bimekizumab 在成人中轴型脊柱关节炎或银屑病关节炎患者中的长期安全性：六项 IIb/III 期临床研究的最新分析

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2025-006174
Mease, Philip J; Merola, Joseph F; Magrey, Marina; Nash, Peter; Poddubnyy, Denis; Lebwohl, Mark; Bajracharya, Rajan; Ink, Barbara; Marten, Alexander; Manente, Myriam; Peterson, Luke; White, Katy; Gensler, Lianne S
关节炎
银屑病
发表日期：2026
文献求助 收藏

Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies

乌帕替尼或阿达木单抗对类风湿性关节炎和银屑病关节炎疼痛的影响：随机3期研究结果

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2025-005867
Taylor, Peter C; Kavanaugh, Arthur; Bessette, Louis; Fautrel, Bruno; Takeuchi, Tsutomu; Garrison, Andrew; Gao, Tianming; Lippe, Ralph; Caballero, Diane; Phillips, Charles; Mease, Philip J
关节炎
银屑病
发表日期：2026
文献求助 收藏

Relationship of radiographic progression status to low disease activity in patients with PsA receiving secukinumab treatment for 2 years

接受司库奇尤单抗治疗 2 年的银屑病关节炎患者的放射学进展状态与低疾病活动度之间的关系

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/keaf488
Mease, Philip J; Coates, Laura C; Gaillez, Corine; Shew, Alexis; Bao, Weibin; Ritchlin, Christopher T
关节炎
银屑病
发表日期：2026
文献求助 收藏

Real-World Comparison of On-Label Treatment Persistence Through 24 Months Between Patients with Psoriatic Arthritis Initiating Guselkumab or Subcutaneous Interleukin-17A Inhibitors

真实世界中，接受古塞库单抗或皮下注射白细胞介素-17A抑制剂治疗的银屑病关节炎患者的持续用药情况比较（24个月）

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03416-z
Mease, Philip J; Walsh, Jessica A; Fitzgerald, Timothy P; Chakravarty, Soumya D; Adamson, Elizabeth; Emond, Bruno; Rossi, Carmine; Schwartzbein, Samuel; Yokoji, Kana; Wang, Yuxi; Lefebvre, Patrick; Pilon, Dominic; Singla, Shikha; Merola, Joseph F
关节炎
银屑病
细胞生物学
发表日期：2026
文献求助 收藏

On-Label Treatment Persistence Through 24 Months Among Patients with Active Psoriatic Arthritis Initiating Guselkumab or Subcutaneous Tumor Necrosis Factor Inhibitors

接受古塞库单抗或皮下注射肿瘤坏死因子抑制剂治疗的活动性银屑病关节炎患者，其按标签用药的持续性达 24 个月

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00804-3
Mease, Philip J; Walsh, Jessica A; Fitzgerald, Timothy P; Chakravarty, Soumya D; Adamson, Elizabeth; Emond, Bruno; Rossi, Carmine; Schwartzbein, Samuel; Yokoji, Kana; Wang, Yuxi; Lefebvre, Patrick; Pilon, Dominic; Singla, Shikha; Merola, Joseph F
关节炎
银屑病
肿瘤免疫
肿瘤
发表日期：2026
文献求助 收藏

Effectiveness of Tofacitinib in Patients with Psoriatic Arthritis Initiating Monotherapy Versus Combination Therapy: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

托法替尼单药治疗与联合治疗在银屑病关节炎患者中的疗效比较：来自CorEvitas银屑病关节炎/脊柱关节炎注册研究的结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00811-4
Ogdie, Alexis; Middaugh, Nicole; Blachley, Taylor; Bourgeois, Tran; Ling, You-Li; Mundayat, Rajiv; Fallon, Lara; Masri, Karim R; Mease, Philip J
关节炎
银屑病
发表日期：2026
文献求助 收藏

Influence of Biological Sex on Participant Characteristics, Guselkumab Efficacy and Radiographic Progression in Active Psoriatic Arthritis: Post Hoc Analysis of Three Randomized Trials

生物性别对活动性银屑病关节炎患者特征、古塞库单抗疗效和放射学进展的影响：三项随机试验的事后分析

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00812-3
Gladman, Dafna D; Eder, Lihi; Selmi, Carlo; Mease, Philip J; Ogdie, Alexis; Lozenski, Karissa; Adamson, Elizabeth; Sharaf, Mohamed; Rampakakis, Emmanouil; Pina Vegas, Laura; Coates, Laura C
关节炎
银屑病
发表日期：2026
文献求助 收藏

Quantifying Disease Activity Despite Treatment with Tumor Necrosis Factor Inhibitors Among Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Real-World Results from the PPD CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

量化接受肿瘤坏死因子抑制剂治疗的银屑病关节炎和中轴型脊柱关节炎患者的疾病活动度：来自 PPD CorEvitas 银屑病关节炎/脊柱关节炎注册研究的真实世界结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00813-2
Mease, Philip; Ye, Xiaolan; Saffore, Christopher D; Parikh, Bhumik; Ciecinski, Sandra; Blachley, Taylor; Eliot, Melissa; Middaugh, Nicole; Ogdie, Alexis
关节炎
银屑病
肿瘤免疫
肿瘤
发表日期：2026
文献求助 收藏

APMAT analysis reveals the association between CD8 T cell receptors, cognate antigen, and T cell phenotype and persistence

APMAT 分析揭示了 CD8 T 细胞受体、同源抗原、T 细胞表型和持久性之间的关联

期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-025-56659-3
Jingyi Xie ，Daniel G Chen ，William Chour ，Rachel H Ng ，Rongyu Zhang ，Dan Yuan ，Jongchan Choi ，Michaela McKasson ，Pamela Troisch ，Brett Smith ，Lesley Jones ，Andrew Webster ，Yusuf Rasheed ，Sarah Li ，Rick Edmark ，Sunga Hong ，Kim M Murray ，Jennifer K Logue ，Nicholas M Franko ，Christopher G Lausted ，Brian Piening ，Heather Algren ，Julie Wallick ，Andrew T Magis ，Kino Watanabe ，Phil Mease ，Philip D Greenberg ，Helen Chu ，Jason D Goldman ，Yapeng Su ，James R Heath
信号转导
T细胞
T Cell Receptor
CD8
发表日期：2025
文献求助 收藏